Bristol-Myers Squibb Company

Bristol-Myers Squibb Company - Enterprise Valueverified

0R1F.L

Bristol-Myers Squibb Company is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, and commercialization of pharmaceutical products. Its extensive portfolio of medicines targets a wide array of serious medical conditions, including those in the fields of hematology, oncology, cardiovascular health, immunology, fibrotic disorders, neuroscience, and COVID-19. The company's prominent therapies include Revlimid, an oral immunomodulator prescribed for multiple myeloma; Eliquis, an oral inhibitor used to lower the risk of stroke/systemic embolism in non-valvular atrial fibrillation and to treat deep vein thrombosis/pulmonary embolism; and Opdivo, a key anti...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2014-11-05

Stock Exchange

LSE

Ticker

0R1F.L

The Enterprise Value as of September 2026 (TTM) for Bristol-Myers Squibb Company (0R1F.L) is 165.15B

According to Bristol-Myers Squibb Company’s latest financial reports and current stock price. The company's current Enterprise Value is 165.15B. This represents a change of 12.52% compared to the average of 146.77B of the last 4 quarters.

Bristol-Myers Squibb Company (0R1F.L) Historical Enterprise Value (quarterly & annually)

How has 0R1F.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Bristol-Myers Squibb Company over the last ten years is 140.42B. The current 165.15B Enterprise Value has changed 11.66% with respect to the historical average. Over the past ten years (40 quarters), 0R1F.L's Enterprise Value was at its highest in in the June 2022 quarter at 196.53B. The Enterprise Value was at its lowest in in the June 2019 quarter at 72.18B.

Quarterly (TTM)
Annual

Average

140.42B

Median

145.83B

Minimum

85.32B

Maximum

184.85B

Bristol-Myers Squibb Company (0R1F.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bristol-Myers Squibb Company Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 69.52%

Maximum Annual Enterprise Value = 184.85B

Minimum Annual Increase = -26.34%

Minimum Annual Enterprise Value = 85.32B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025147.02B-5.45%
2024155.50B14.20%
2023136.16B-26.34%
2022184.85B8.67%
2021170.10B-4.00%
2020177.19B22.51%
2019144.64B69.52%
201885.32B-17.44%
2017103.35B3.22%
2016100.12B-15.85%

Bristol-Myers Squibb Company (0R1F.L) Average Enterprise Value

How has 0R1F.L Enterprise Value performed in the past?

The current Enterprise Value of Bristol-Myers Squibb Company (0R1F.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

146.23B

5-year avg

158.73B

10-year avg

140.42B

Bristol-Myers Squibb Company (0R1F.L) Enterprise Value vs. Peers

How is 0R1F.L’s Enterprise Value compared to its peers?

Bristol-Myers Squibb Company’s Enterprise Value is less than AbbVie Inc. (512.59B), greater than DMK Pharmaceuticals Corporation (-737792.00), less than Meridian Bioscience, Inc. (0), greater than Patterson Companies, Inc. (3.42B), greater than Endo International plc (6.57B), greater than Walgreens Boots Alliance, Inc. (42.82B), greater than Unity Biotechnology, Inc. (19.40M), greater than bluebird bio, Inc. (344.60M), greater than QuidelOrtho Corporation (3.78B), greater than Imunon, Inc. (7.03M),

Build a custom stock screener for Bristol-Myers Squibb Company (0R1F.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bristol-Myers Squibb Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bristol-Myers Squibb Company (0R1F.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bristol-Myers Squibb Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bristol-Myers Squibb Company's Enterprise Value?

What is the highest Enterprise Value for Bristol-Myers Squibb Company (0R1F.L)?

What is the 3-year average Enterprise Value for Bristol-Myers Squibb Company (0R1F.L)?

What is the 5-year average Enterprise Value for Bristol-Myers Squibb Company (0R1F.L)?

How does the current Enterprise Value for Bristol-Myers Squibb Company (0R1F.L) compare to its historical average?